Ear Infection Treatment Market growth to accelerate at 5.44% CAGR | Maximum growth expected in APAC

NEW YORK , March 21, 2022 /PRNewswire/ — The global ear infection treatment market size is expected to grow by USD 503.96 billion, expanding at a CAGR of 5.44% during the forecast period. The report expects the market to have the maximum growth in APAC. The rapidly evolving healthcare industry and the presence of a dense population base in the region are creating several growth opportunities for market players.

Get more highlights on the CAGR, incremental growth, and future growth opportunities in the market.
Download a Free Sample Report

The 120-page report with TOC analyzes the ear infection treatment market by type (middle ear infections, outer ear infections, and inner ear infections) and geography (North America, Europe, Asia, and Rest of World (ROW)).

The ear infection treatment market is driven by the high-risk factors for ear infections. In addition, rising funding for research on ear infections is anticipated to boost the growth of the ear infection treatment market.

Ear infections mainly affect the ear canal, the middle ear, or the inner ear. These infections are caused due to various risk factors such as bacteria, viral cold or flu, injury to the ear, or smoking. According to a study, nearly 40 million adults in the US smoke cigarettes, and about 4.7 million middle and high school students use at least one tobacco product, including e-cigarettes. This is increasing the prevalence of various diseases including lung diseases and ear infections. Similarly, on average, adults have 2 to 3 colds per year, and children have even more. Such high-risk factors are increasing the incidence of ear infections, thereby driving the growth of the ear infection treatment market.

Major Ear Infection Treatment Market Players:

The global ear infection treatment market is fragmented with the presence of leading and well-established pharmaceutical players. The market is likely to witness slight vendor dilution with the increasing popularity of antibiotics and various other symptomatic treatment options. Currently, the market does not have a strong pipeline as the available therapeutics are used for symptomatic treatment only. Hence, companies focus on R&D to meet the unmet need, which will further intensify the competition among them. The following are identified as the dominant players in the market.

Story continues

• Akorn Inc.

• Aurobindo Pharma Ltd.

• Biovea

• Zydus Lifesciences Ltd.

• Fresenius SE and Co. KGaA

• GlaxoSmithKline Plc

• Hyland

• Johnson and Johnson

• Lupin Ltd.

• Merck and Co. Inc.

• Mylan NV

• Novartis AG

• Otonomy Inc.

• Perrigo Co. Plc

• Sensorion

• Sun Pharmaceutical Industries Ltd.

• Wockhardt Ltd.

• WraSer Pharmaceuticals

• Pfizer Inc.

• F. Hoffmann La Roche Ltd.

Know about other key driving factors and dominant players in the market. Request a Free Sample Report

Ear Infection Treatment Market Type Outlook (Revenue, USD billion, 2021-2026)

• Middle ear infections – size and forecast 2021-2026

• Outer ear infections – size and forecast 2021-2026

• Inner ear infections – size and forecast 2021-2026

The market observed maximum growth in the middle ear infections segment in 2021. The high prevalence of AOM infection is one of the major drivers for the segment. In addition, extensive R&D efforts by vendors to launch new drugs are also driving the growth of the segment. The market growth in the segment will be significant during the forecast period.

Ear Infection Treatment Market Geography Outlook (Revenue, USD billion, 2021-2026)

• North America – size and forecast 2021-2026

• Europe – size and forecast 2021-2026

• Asia – size and forecast 2021-2026

• Rest of World (ROW) – size and forecast 2021-2026

North America will have the largest share of the market. The region currently holds 37% of the global market share. The availability of improved ear infection treatment options such as developed surgical treatment and diagnostics tools has been crucial in driving the growth of the ear infection treatment market in North America. The US and Canada are the key markets for ear infection treatment in North America. Countries such as Denmark, China, and India will also emerge as major markets for ear infection treatment during the forecast period.

Identify other revenue-generating segments, regions, and countries in the market.
Download a Free Sample Report

Related Reports:

Middle Ear Implants Market by Product, Application, and Geography – Forecast and Analysis 2022-2026

ENT Devices Market by Product and Geography – Forecast and Analysis 2021-2025

Table of Contents:

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Five Forces Analysis

5 Market Segmentation by Type

6 Customer Landscape

7 Geographic Landscape

8 Drivers, Challenges, and Trends

9 Vendor Landscape

10 Vendor Analysis

11 Appendix

About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/ear-infection-treatment-market-growth-to-accelerate-at-5-44-cagr–maximum-growth-expected-in-apac–technavio-301505390.html

SOURCE Technavio